Association for Molecular Pathology Inc
Public records show a registered, tax-exempt organization in good standing.
What it says it does
ADVANCES THE CLINICAL PRACTICE, SCIENCE, AND EXCELLENCE OF MOLECULAR AND GENOMIC LABORATORY MEDICINE THROUGH EDUCATION, INNOVATION, AND ADVOCACY TO ENABLE HIGHEST QUALITY HEALTH CARE.
- Income
- $6.3 million
- Spending
- $7.5 million
- Spent on programs
- 75%
- Reserves
- 19.7 months of spending
- Largest source of income
- fees for its services, 77%
- Employees
- 20
- Volunteers
- 411
- Highest pay
- $385,837, chief executive officer-start 1/3/24
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Good: 76 out of 100. Higher than 62% of charities in its peer group (education, $1m to $10m).
Reserves
35 of 35Spendable reserves would cover 19.7 months of spending.
Debt
16 of 20It owes 20% of what it owns.
Living within its means
0 of 15Spending exceeded income by 19% of income.
Income trend
10 of 15Income fell 1% on the year before.
Spending floor
15 of 1575% of spending went to programs and raising each dollar of donations cost 0 cents.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Strong: 100 out of 100. Higher than 74% of charities in its peer group (education, $1m to $10m).
Independent board
25 of 2519 of 19 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Pay set independently
5 of 5Sets its chief executive's pay through independent review and comparison.
Independent check of accounts
15 of 15Its accounts were audited by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (4)
- $2.8 million spent. SCIENTIFIC SYMPOSIA AND MEETINGS THE ORGANIZATION BRINGS TOGETHER SCIENTISTS FOR THE PROMOTION OF CLINICAL PRACTICE, BASIC RESEARCH, AND EDUCATION IN MOLECULAR PATHOLOGY. IN 2024, AMP'S ANNUAL MEETING & EXPO WAS HELD IN VANCOUVER, BRITISH COLUMBIA, CANADA. THIS THREE-DAY EVENT FEATURED MORE THAN 25 HOURS OF CUTTING-EDGE SESSIONS, 507 POSTERS, 153 EXHIBITORS, AND COUNTLESS OPPORTUNITIES TO INTERACT DIRECTLY WITH COLLEAGUES. THERE WERE 1768 REGISTRANTS. IN NOVEMBER 2024, AMP HELD GET AMPED!, A LIVE EDUCATIONAL AND INTERACTIVE COURSE DESIGNED TO BRING ATTENDEES UP TO SPEED IN MOLECULAR PATHOLOGY. THE THEME OF THE COURSE WAS, "NEW, EMERGING, AND TRIED AND TRUE TECHNOLOGIES IN MOLECULAR PATHOLOGY WITH INTERACTIVE CASE STUDIES." THE COURSE LEARNING OBJECTIVES WERE TO: - DESCRIBE THE MECHANISM OF OPTICAL GENOME MAPPING AND ITS IMPORTANT APPLICATIONS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS; - DESCRIBE THE ROLE OF INFORMATICS IN PROCESSING CLINICAL MOLECULAR DATA; - FACULTY MEMBERS PRESENT AN IMMERSIVE WORKSHOP OF CASE STUDIES WHERE PARTICIPANTS BREAK OUT INTO SMALL GROUPS TO WORK THROUGH CLINICAL MOLECULAR CASES. MOLECULAR GENETIC PATHOLOGY REVIEW COURSE AMP HAD ITS FIRST MGP REVIEW COURSE IN 2007. IT THEN HAD A LIVE EVENT IN THE ODD YEARS FROM 2009 THROUGH 2023. STARTING IN 2021, THE COURSE WAS PROVIDED AS A LIVE VIRTUAL EVENT. THE LIVE EVENT WAS RECORDED STARTING IN 2017 AND OFFERED AS AN ONLINE COURSE UNTIL THE NEXT LIVE COURSE WAS OFFERED. THE REVENUE FROM RECORDED SESSIONS IS ACCOUNTED FOR IN ONLINE EDUCATION. THE COURSE FEATURES MULTI-DAY INTENSE INSTRUCTION ON UPDATES IN THE FIELD AND REVIEW OF MOLECULAR PATHOLOGY CORE CONCEPTS THAT IS PRIMARILY FOCUSED ON PREPARATION FOR THE MOLECULAR GENETIC PATHOLOGY (MGP) SUBSPECIALTY CERTIFICATION EXAM, AS WELL AS OTHER CERTIFICATION EXAMS. AMP EUROPE 2024 WAS HELD IN MADRID, SPAIN ON JUNE 24 TO 26, WITH 306 ATTENDEES, 16 EXHIBITORS, 18 EDUCATIONAL SESSIONS (PLUS 7 INDUSTRY SYMPOSIA) AND 105 POSTERS. AWARDS WERE PRESENTED FOR TRAVEL SUPPORT AND YOUNG INVESTIGATOR POSTER PRESENTATION.
- $320,975 spent. COMMUNICATION & OUTREACH: MEMBERSHIP SERVICES - WEBSITE, NEWSLETTERS, ETC.PROMOTE GENERAL EFFECTIVENESS AND PROVIDE A FORUM FOR DISCUSSION AND A MEANS OF EXCHANGING INFORMATION.
- $558,685 spent. INNOVATION AND IMPROVED PATIENT CARE (IIPC) - SEE SCHEDULE O FOR COMPLETE DESCRIPTIONIIPC WORKS TO FOSTER INNOVATION TO IMPROVE PATIENT CARE AND PATIENT OUTCOMES THROUGH PROGRAMS THAT INCLUDE ISSUING MANUSCRIPTS, CLINICAL PRACTICE GUIDELINES, REPORTS, AND OVERSIGHT OF JMD'S STRATEGIC DIRECTION.THE JOURNAL OF MOLECULAR DIAGNOSTICSTHIS IS THE OFFICIAL JOURNAL OF AMP. MONTHLY PUBLICATION BEGAN IN JANUARY 2020. THESE ISSUES HAVE ORIGINAL, HIGH-QUALITY MANUSCRIPTS ON SCIENTIFIC ADVANCES IN THE TRANSLATION AND VALIDATION OF MOLECULAR DISCOVERIES IN MEDICINE INTO THE CLINICAL DIAGNOSTIC SETTING, AND THE DESCRIPTION AND APPLICATION OF TECHNOLOGICAL ADVANCES IN THE FIELD OF MOLECULAR DIAGNOSTIC MEDICINE.EVERY PUBLISHED MANUSCRIPT IS SCIENTIFICALLY PEER REVIEWED.JMD IS JOINTLY OWNED WITH THE AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY (ASIP) 94-6079945. STARTING IN 2011, ELSEVIER BEGAN PUBLISHING JMD.
- $1.9 million spent. ADVOCACYTHE AMP ADVOCACY PROGRAM ENDEAVORS TO INFORM AND INFLUENCE PUBLIC POLICY AFFECTING MOLECULAR PATHOLOGY. AMP REPRESENTS ITS MEMBERSHIP TO THE FEDERAL AGENCIES AND MEMBERS OF CONGRESS REGARDING PROFESSIONAL AND REIMBURSEMENT ISSUES - REACHING OUT TO FELLOW PROFESSIONAL ASSOCIATIONS, INDUSTRY AND OTHER ASSOCIATION PARTNERS TO ACCOMPLISH COMMON GOALS.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated November 6, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2024.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since December 1999.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated November 4, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.